213 related articles for article (PubMed ID: 30412630)
1. Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
Gezelius E; Flou Kristensen A; Bendahl PO; Hisada Y; Risom Kristensen S; Ek L; Bergman B; Wallberg M; Falkmer U; Mackman N; Pedersen S; Belting M
PLoS One; 2018; 13(11):e0207387. PubMed ID: 30412630
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial.
Ek L; Gezelius E; Bergman B; Bendahl PO; Anderson H; Sundberg J; Wallberg M; Falkmer U; Verma S; Belting M;
Ann Oncol; 2018 Feb; 29(2):398-404. PubMed ID: 29106448
[TBL] [Abstract][Full Text] [Related]
3. Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN).
Gezelius E; Bendahl PO; Gonçalves de Oliveira K; Ek L; Bergman B; Sundberg J; Strandberg K; Krämer R; Belting M
Eur J Cancer; 2019 Sep; 118():82-90. PubMed ID: 31326730
[TBL] [Abstract][Full Text] [Related]
4. Increased activity of procoagulant factors in patients with small cell lung cancer.
Pedersen S; Kristensen AF; Falkmer U; Christiansen G; Kristensen SR
PLoS One; 2021; 16(7):e0253613. PubMed ID: 34288927
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study.
van Es N; Hisada Y; Di Nisio M; Cesarman G; Kleinjan A; Mahé I; Otten HM; Kamphuisen PW; Berckmans RJ; Büller HR; Mackman N; Nieuwland R
Thromb Res; 2018 Jun; 166():54-59. PubMed ID: 29656167
[TBL] [Abstract][Full Text] [Related]
6. Tissue Factor As a Predictor of Recurrent Venous Thromboembolism in Malignancy: Biomarker Analyses of the CATCH Trial.
Khorana AA; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Lee AY
J Clin Oncol; 2017 Apr; 35(10):1078-1085. PubMed ID: 28029329
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer.
Moik F; Prager G; Thaler J; Posch F; Wiedemann S; Schramm T; Englisch C; Mackman N; Pabinger I; Ay C
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2837-2847. PubMed ID: 34470475
[TBL] [Abstract][Full Text] [Related]
8. Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.
D'Alessio A; Marchetti M; Tartari CJ; Russo L; Cecchini S; Lambregts KWFM; di Mauro D; Falanga A
Cancer Invest; 2017 Aug; 35(7):490-499. PubMed ID: 28692314
[TBL] [Abstract][Full Text] [Related]
9. Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC Trial.
Macbeth F; Noble S; Evans J; Ahmed S; Cohen D; Hood K; Knoyle D; Linnane S; Longo M; Moore B; Woll PJ; Appel W; Dickson J; Ferry D; Brammer C; Griffiths G
J Clin Oncol; 2016 Feb; 34(5):488-94. PubMed ID: 26700124
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma.
Nielsen T; Kristensen SR; Gregersen H; Teodorescu EM; Christiansen G; Pedersen S
PLoS One; 2019; 14(1):e0210835. PubMed ID: 30640949
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
[TBL] [Abstract][Full Text] [Related]
12. Vitamin K Antagonists Compared to Low-Molecular-Weight Heparins for Treatment of Cancer-Associated Venous Thromboembolism: An Observational Study in Routine Clinical Practice. An Observational Study in Routine Clinical Practice.
den Exter PL; Hooijer J; van der Hulle T; van Oosten JP; Dekkers OM; Klok FA; Huisman MV
Thromb Haemost; 2017 Nov; 117(11):2163-2167. PubMed ID: 28981552
[TBL] [Abstract][Full Text] [Related]
13. Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy.
Abu Saadeh F; Langhe R; Galvin DM; O Toole SA; O'Donnell DM; Gleeson N; Norris LA
Thromb Res; 2016 Mar; 139():135-41. PubMed ID: 26916311
[TBL] [Abstract][Full Text] [Related]
14. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients.
Zhu LR; Li J; Chen P; Jiang Q; Tang XP
Clin Transl Oncol; 2016 Feb; 18(2):178-88. PubMed ID: 26184726
[TBL] [Abstract][Full Text] [Related]
16. Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study.
Donadini MP; Dentali F; Pegoraro S; Pomero F; Brignone C; Guasti L; Steidl L; Ageno W
Vasc Med; 2017 Dec; 22(6):518-524. PubMed ID: 28732457
[TBL] [Abstract][Full Text] [Related]
17. Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer.
Kourelis TV; Wysokinska EM; Wang Y; Yang P; Mansfield AS; Tafur AJ
Lung Cancer; 2014 Dec; 86(3):358-62. PubMed ID: 25453848
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy.
Liu X; Zhang W; Yin W; Xiao Y; Zhou C; Hu Y; Geng S
Medicine (Baltimore); 2017 Nov; 96(46):e8258. PubMed ID: 29145241
[TBL] [Abstract][Full Text] [Related]
19. Tissue factor activity on microvesicles from cancer patients.
Ender F; Freund A; Quecke T; Steidel C; Zamzow P; von Bubnoff N; Gieseler F
J Cancer Res Clin Oncol; 2020 Feb; 146(2):467-475. PubMed ID: 31734835
[TBL] [Abstract][Full Text] [Related]
20. [Cancer and venous thromboembolism].
Meyer G; Belmont L
Rev Mal Respir; 2011 Apr; 28(4):443-52. PubMed ID: 21549900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
